More Than 200 Preventive Vaccines, Developed By Both Industry And Non-industry Players, Are Being Evaluated In Clinical Stages Of Development

By Author: sumanbutler
Total Articles: 9
Comment this article

To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this –
https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

The USD 94 billion (by 2030) financial opportunity within the global preventive vaccine market has been analyzed across the following segments:
 Route of Administration
 Intramuscular
 Subcutaneous
 Oral
 Intravenous
 Others

 Type of Vaccine
 Pneumococcal Conjugate Vaccine
 Human Papilloma Virus Vaccine
 Rotavirus Vaccine
 Influenza Vaccine
 MMR Vaccine
 Tetanus and Diphtheria Booster Vaccine
 Varicella Vaccine
 DTaP-Hib-IPV Vaccine
 DTaP-HepB-Hib-IPV Vaccine
 Others

 Type of Vaccine API
 Live, Attenuated Vaccine
 Inactivated Vaccine
 Conjugate Vaccine
 Subunit Vaccine
 Toxoid Vaccine
 Others

 Target Patient Population
 Pediatric Patients
 Adults

 Key Players
 GlaxoSmithKline
...
...  Merck
 Sanofi Pasteur
 Pfizer
 Emergent BioSolutions
 CSL
 Others

 Key Geographical Regions
 North America
 Europe
 Asia Pacific
 Rest of the World

The Global Preventive Vaccines Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:
 Bio Farma
 Emergent BioSolutions
 GC Pharma
 GlaxoSmithKline
 Janssen
 Merck
 Novavax
 Pfizer
 Sanofi Pasteur
 Valneva

To request for sample report - https://www.rootsanalysis.com/reports/318/request-sample.html

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Clinical Trial Analysis

8. Ongoing Vaccine Development Initiatives for Complex Conditions

9. Funding and Investment Analysis

10. Market Sizing and Opportunity Analysis

11. Case-in-Point: Contract Manufacturing of Vaccines

12. Concluding Remarks

13. Executive Insights

14. Appendix 1: Tabulated Data

15. Appendix 2: List of Companies and Organizations

Other Recent Offerings:
1. Antibody Drug Conjugates Market (5th Edition), 2019-2030
2. Gene Therapy Market (3rd Edition), 2019 - 2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
4. Synthetic Lethality-based Drugs and Targets Market, 2019-2030

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis